Anthony Tilmans, MD
Radiation Oncology · Muncie, INNPI 1275635260
Payments from drug & device makers
What this record shows
This record is dominated by other: $3,607 of the $3,820 with a category attached, or 94.4%. Stryker accounts for 94.4% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2024 at $3,607 and has fallen 94.9% since, to $184 in 2025. Among radiation oncology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $318.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$4K
- Adaptive Biotechnologies Corporation$49
- Servier Pharmaceuticals LLC$24
- Genmab U.S., Inc.$24
- Siemens Medical Solutions USA, Inc.$23
- Novartis$19
- plus $74 from 5 others
What the payments were for
- Food & beverage$2136%
- Other$3,60794%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 1 | $3,607 |
| Adaptive Biotechnologies Corporation | 2 | $49 |
| Servier Pharmaceuticals LLC | 1 | $24 |
| Genmab U.S., Inc. | 1 | $24 |
| Siemens Medical Solutions USA, Inc. | 1 | $23 |
| Novartis | 1 | $19 |
| Merck | 1 | $16 |
| Boston Scientific | 1 | $16 |
| Genentech USA, Inc. | 1 | $16 |
| Deciphera Pharmaceuticals Inc. | 1 | $14 |
| GSK | 1 | $13 |
How this compares
$3,820 in reported general payments places this provider in the 90th percentile of 116 radiation oncology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lidocaine Hcl ViscousLidocaine Hcl | 12 | $84 |
| Mupirocin | 13 | $75 |
Paid to pharmacies, not to this prescriber.
Other radiation oncology in Muncie
- Brian ChangFort Wayne$13K
- Michael EatonIndianapolis$11K
- William PorterMadison$8K
- Binh TranMishawaka$7K
- Gordon WatsonIndianapolis$6K
- John CoxIndianapolis$5K
- Houman VaghefiGoshen$5K
- Peter GarrettIndianapolis$5K
- Garrett JensenIndianapolis$4K
- Douglas DebenhamNewburgh$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.